Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Exploration of anxiety sensitivity and distress tolerance as vulnerability factors for hoarding behaviors.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: Wiley Country of Publication: United States NLM ID: 9708816 Publication Model: Print Cited Medium: Internet ISSN: 1520-6394 (Electronic) Linking ISSN: 10914269 NLM ISO Abbreviation: Depress Anxiety Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: New York, NY : Wiley, c1997-
    • الموضوع:
    • نبذة مختصرة :
      Background: The phenomenon of compulsive hoarding, characterized by the acquisition of and failure to discard a large number of possessions, is increasingly recognized as a significant public health burden. Despite the magnitude of the impairment associated with this condition, empirical research is still in the nascent stages and many facets of the phenomenology, underlying vulnerability and risk factors for hoarding, are as of yet unknown.
      Method: The overall aim of the current investigation was to examine the association between hoarding behaviors and two potential vulnerability factors-anxiety sensitivity (AS) and distress tolerance (DT). In addition, we investigated the robustness of these associations as well as the interaction between the two hypothesized risk factors. Three studies (total N=745) involving independent nonclinical samples assessed hoarding, AS, DT, and relevant covariates using a range of measures. Resutlts: Findings revealed that AS and hoarding are significantly and robustly associated with one another beyond general depressive, anxiety, and nonhoarding obsessive-compulsive symptoms. Hoarding was also found to be associated with low DT. Consistent with prediction, AS and DT interacted such that DT may play a less important role among individuals with low AS. By contrast, low DT appears to increase vulnerability to hoarding symptoms among individuals high in AS. Results are discussed with regard to future research and treatment implications. Depression and Anxiety, 2009. Published 2009 Wiley-Liss, Inc.
    • References:
      Clin Psychol Rev. 2003 Dec;23(7):905-27. (PMID: 14624821)
      Addict Behav. 2007 Sep;32(9):1957-63. (PMID: 17258398)
      J Anxiety Disord. 2003;17(5):583-91. (PMID: 12941368)
      J Consult Clin Psychol. 2004 Aug;72(4):646-52. (PMID: 15301649)
      Behav Ther. 2007 Sep;38(3):247-55. (PMID: 17697850)
      J Anxiety Disord. 2001 Sep-Oct;15(5):367-93. (PMID: 11583071)
      J Pediatr Psychol. 2002 Jan-Feb;27(1):87-96. (PMID: 11726683)
      J Anxiety Disord. 2006;20(7):837-57. (PMID: 16466904)
      J Anxiety Disord. 2006;20(3):263-80. (PMID: 16564432)
      Clin Psychol Rev. 2005 Sep;25(6):713-33. (PMID: 16023275)
      Acta Psychiatr Scand. 2006 May;113(5):440-6. (PMID: 16603035)
      J Gambl Stud. 2005 Winter;21(4):363-78. (PMID: 16311873)
      J Abnorm Psychol. 2005 Nov;114(4):729-34. (PMID: 16351393)
      Cogn Behav Ther. 2006;35(4):248-56. (PMID: 17189242)
      Behav Res Ther. 1993 May;31(4):367-81. (PMID: 8512538)
      Arch Gen Psychiatry. 2006 Jul;63(7):757-66. (PMID: 16818865)
      Depress Anxiety. 2007;24(8):527-36. (PMID: 17136755)
      Behav Res Ther. 1996 Apr;34(4):341-50. (PMID: 8871366)
      Psychol Rev. 2001 Jan;108(1):4-32. (PMID: 11212632)
      Behav Res Ther. 2003 Feb;41(2):179-94. (PMID: 12547379)
      Psychol Assess. 2002 Dec;14(4):485-96. (PMID: 12501574)
      Behav Res Ther. 2000 Nov;38(11):1071-81. (PMID: 11060936)
      J Clin Psychiatry. 1998 May;59(5):267-72; quiz 273. (PMID: 9632043)
      J Abnorm Psychol. 1997 Aug;106(3):355-64. (PMID: 9241937)
      J Psychiatr Res. 2006 Dec;40(8):691-9. (PMID: 16956622)
      J Consult Clin Psychol. 1988 Dec;56(6):893-7. (PMID: 3204199)
      Health Soc Care Community. 2000 Jul;8(4):229-234. (PMID: 11560692)
      Int J Geriatr Psychiatry. 2007 Feb;22(2):131-43. (PMID: 17096462)
      J Abnorm Psychol. 1999 Aug;108(3):532-7. (PMID: 10466277)
      Biol Psychiatry. 2006 Jul 15;60(2):93-105. (PMID: 16406007)
      Behav Res Ther. 2005 Apr;43(4):521-32. (PMID: 15701361)
      Biol Psychiatry. 2007 Mar 1;61(5):617-25. (PMID: 17027929)
      Nat Med. 1998 Nov;4(11):1241-3. (PMID: 9809543)
      Am J Psychiatry. 2003 Apr;160(4):636-45. (PMID: 12668349)
      Psychol Bull. 1991 Jul;110(1):129-36. (PMID: 1891514)
      Psychol Assess. 2007 Jun;19(2):176-88. (PMID: 17563199)
      J Clin Psychiatry. 2002;63 Suppl 6:30-3. (PMID: 12027117)
      Behav Res Ther. 1998 Jul-Aug;36(7-8):657-64. (PMID: 9682522)
      Neuropsychopharmacology. 2004 Oct;29(10):1765-81. (PMID: 15213704)
      Am J Psychiatry. 2004 Jun;161(6):1038-48. (PMID: 15169692)
      Behav Res Ther. 2002 May;40(5):517-28. (PMID: 12043707)
      Behav Modif. 1996 Jan;20(1):116-32. (PMID: 8561769)
      Br J Clin Psychol. 2005 Jun;44(Pt 2):227-39. (PMID: 16004657)
      Brain Dev. 2003 Dec;25 Suppl 1:S55-61. (PMID: 14980374)
      Behav Res Ther. 2004 Oct;42(10):1163-82. (PMID: 15350856)
    • Grant Information:
      R21 MH062056 United States MH NIMH NIH HHS; F31 DA021457 United States DA NIDA NIH HHS; Z01 MH000336-29 United States ImNIH Intramural NIH HHS; F31 DC012457 United States DC NIDCD NIH HHS; R01 MH064734-04A1 United States MH NIMH NIH HHS; R21 MH62056 United States MH NIMH NIH HHS; F31 DA021457-01 United States DA NIDA NIH HHS; F31 DA12457-01 United States DA NIDA NIH HHS; F31 MH080467 United States MH NIMH NIH HHS; P50 HD052120 United States HD NICHD NIH HHS; R01 MH064734 United States MH NIMH NIH HHS; F31 MH080467-01A1 United States MH NIMH NIH HHS
    • الموضوع:
      Date Created: 20090107 Date Completed: 20090814 Latest Revision: 20220408
    • الموضوع:
      20221213
    • الرقم المعرف:
      PMC2770430
    • الرقم المعرف:
      10.1002/da.20469
    • الرقم المعرف:
      19123454